-
Maresca uncertain over Rodri's future at Man City
-
Hotter Europe isn't cooling investor fervor for stocks
-
MEXC's August 2026 Proof of Reserves Confirms User Assets Fully Backed as Reserve Ratios Remain Above 100%
-
Duplantis into pole vault final at Euros
-
Zambia suspends vote counting nationwide citing violence
-
Maresca says 'anything can happen' amid talk of Rodri move to Barcelona
-
Coe pledges court showing to defend World Athletics over Russia stance
-
Indonesian leader vows to shut over 750 'unproductive' state-owned firms
-
Stocks mixed as oil climbs, dollar drops
-
NATO jets shoot down drone in Latvian airspace: spokesperson
-
Tourists beat the heat with 'magical' Colosseum night tours
-
Wildfire forces hundreds to flee in western Germany
-
Spain extends largest nuclear plant in policy U-turn
-
Croatian wildfire forces thousands to flee, injures dozens
-
Gill says 'huge honour' to lead India in 600th Test
-
Latest developments: Europe battles wildfires
-
Brazilian police recover Matisse works stolen in 2025
-
Is a new conflict brewing in northern Ethiopia?
-
Exiled Putin critic says push for peace put him in danger
-
UK firefighters 'under pressure' as multiple blazes rage
-
EU to study potential vaccine for Lyme disease: companies
-
ARKBRIDGE Reaches 50,000 Clients and Launches New Referral Rewards Program
-
Colombia vows to find all missing quake victims as rescue hopes fade
-
New wildfire forces evacuation of 500 people in France
-
Farage wins UK by-election as Count Binface claims 'moral victory'
-
ट्रोजन: एक अधिक खतरनाक राजनीतिक युग के लिए विशेष सुरक्षा
-
TROJAN: 더욱 위험해진 정치 시기를 위한 특별 보호 조치
-
『TROJAN』:政治情勢がより危険になる時代に向けた特別な保護策
-
《特洛伊木馬》:在政治局勢日趨險惡的時代,提供特別保護
-
برنامج «TROJAN»: حماية خاصة في ظل أوقات سياسية أكثر خطورة
-
TROJAN: спеціальний захист для більш небезпечних політичних часів
-
TROJAN: Special protection for a more perilous political era
-
Thai schools step up security after deadly shooting
-
Tanzid makes history as Bangladesh dominate first Australia Test
-
Thousands stranded as heavy rain kills at least four in Japan
-
Indonesia to close more than 750 state-owned enterprises
-
McIntosh bounces back with 400m medley win at Pan Pacs
-
US backs Japan over Putin trip to disputed islands
-
Farage declares victory as count still underway in UK by-election
-
'I want to be Eala': Philippine sensation sparks tennis boom at home
-
Australia probes three near-misses at Sydney Airport
-
US says lower oil prices, not Iran's nuclear program, are now top priority in war
-
Classy Tanzid puts Bangladesh in firm charge against Australia
-
Most Asian stocks track Wall St record as US data ease rate fears
-
Schwarber smacks two homers to power Philles' MLB Field of Dreams win
-
China's viral 'spicy strips' take a bite of global snack market
-
Pakistan's date workers toil through rising heat
-
Shelton does the double in Canada
-
New trend of injecting banned peptides to 'optimise' body
-
'Shock' gloves for US immigration agents fuel potential abuse fears
US Supreme Court rejects bid to restrict abortion pill
The US Supreme Court on Thursday rejected a bid to restrict an abortion pill widely used in the United States to terminate pregnancies.
The court, in a unanimous opinion, said the anti-abortion groups and physicians challenging the medication, mifepristone, lacked the legal standing to bring the case.
Abortion rights are one of the key issues in the November election and the administration of Democratic President Joe Biden had urged the court to maintain access to the drug, which was approved by the Food and Drug Administration (FDA) in 2000. His opponent Donald Trump leads a Republican Party broadly favoring blocks to abortion access.
The mifepristone case was the first significant abortion case heard by the conservative-dominated Supreme Court since it overturned the previously long-held constitutional right to abortion two years ago.
"We recognize that many citizens, including the plaintiff doctors here, have sincere concerns about and objections to others using mifepristone and obtaining abortions," said Justice Brett Kavanaugh, who wrote the 9-0 opinion.
"But citizens and doctors do not have standing to sue simply because others are allowed to engage in certain activities," Kavanaugh said. "The plaintiffs lack standing to challenge FDA's actions."
The conservative justice said the federal courts were "the wrong forum for addressing the plaintiffs' concerns about FDA's actions" and they could present their objections through regulatory procedures or through the "political and electoral processes."
Abortion opponents have been seeking to restrict nationwide access to the pill, claiming it is unsafe and that anti-abortion doctors were being forced to violate their conscience by intervening on patients who suffered complications after using it.
A conservative US district court judge in Texas, who was appointed during Trump's presidency, issued a ruling last year that would have banned mifepristone.
An appeals court overturned the outright ban because the statute of limitations on challenging the FDA's approval had expired, but restricted access to the drug.
The appeals court reduced the period during which mifepristone can be used from 10 weeks of pregnancy to seven weeks, blocked it from being delivered by mail, and required the pill to be prescribed and administered by a doctor.
The Supreme Court ruling lifts those restrictions.
Medication abortion accounted for 63 percent of the abortions in the country last year, up from 53 percent in 2020, according to the Guttmacher Institute.
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
N.Shalabi--SF-PST